Myeloma and Related Diseases Registry (MRDR)

Helping clinicians and hospitals to provide the best possible care to people with multiple myeloma and related diseases.

View our 2024 Annual Report Here

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
8737

Patients accrued

6465

Patients with multiple myeloma

67

Number of approved sites

775

M1000 Biobank participants

Latest news

Celebrating Three New MRDR Publications!
10 Nov 2025

Three manuscripts using MRDR data have been published

Read more
MRDR Annual Breakfast Meeting 2025 - Recording Available
27 Oct 2025

The recording of the meeting is now available to view.

Read more
MRDR Events at Blood 2025
23 Oct 2025

Come find our presentations at Blood/ISBT 2025

Read more
MRDR Annual Breakfast Meeting 2025
29 Sep 2025

Register now for the MRDR Annual Breakfast Meeting at Blood 2025!

Read more

Participating organisations